Day One Biopharmaceuticals Inc (DAWN) Is Worth Accumulating At Current Levels
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) concluded the trading at $11.80 on Friday, January 10 with a fall of -3.28% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $12.20 and 5Y monthly